127 related articles for article (PubMed ID: 3448925)
41. Upper urinary tract cancer: location is correlated with prognosis.
van der Poel HG; Antonini N; van Tinteren H; Horenblas S
Eur Urol; 2005 Sep; 48(3):438-44. PubMed ID: 16115524
[TBL] [Abstract][Full Text] [Related]
42. Predictors of upper tract urothelial cell carcinoma after primary bladder cancer: a population based analysis.
Wright JL; Hotaling J; Porter MP
J Urol; 2009 Mar; 181(3):1035-9; discussion 1039. PubMed ID: 19150569
[TBL] [Abstract][Full Text] [Related]
43. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?
Maulard-Durdux C; Dufour B; Hennequin C; Chrétien Y; Vignes B; Droz D; Delanian S; Housset M
J Urol; 1996 Jan; 155(1):115-7. PubMed ID: 7490805
[TBL] [Abstract][Full Text] [Related]
44. [5 cases of renal pelvis and ureteral tumor].
Nishizawa K; Murakami Y; Miyakita H; Hoshino H
Hinyokika Kiyo; 1986 Nov; 32(11):1719-23. PubMed ID: 3825819
[TBL] [Abstract][Full Text] [Related]
45. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
46. Transitional cell carcinoma of the upper urinary tract: analysis of morphology and distribution for surgical management.
Fujimoto H; Tobisu K; Mizutani T; Sakamoto M; Kakizoe T
Jpn J Clin Oncol; 1993 Oct; 23(5):303-8. PubMed ID: 8230755
[TBL] [Abstract][Full Text] [Related]
47. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
[TBL] [Abstract][Full Text] [Related]
48. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis.
Patel A; Soonawalla P; Shepherd SF; Dearnaley DP; Kellett MJ; Woodhouse CR
J Urol; 1996 Mar; 155(3):868-74. PubMed ID: 8583595
[TBL] [Abstract][Full Text] [Related]
49. [Clinical review of conservative management of upper urinary tract transitional cell carcinoma].
Oka H; Shiraishi Y; Negoro H; Iwamura H; Moroi S; Soeda A; Takeuchi H; Kawakita M
Hinyokika Kiyo; 2006 Apr; 52(4):249-53. PubMed ID: 16686350
[TBL] [Abstract][Full Text] [Related]
50. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract.
Kang CH; Yu TJ; Hsieh HH; Yang JW; Shu K; Huang CC; Chiang PH; Shiue YL
Cancer; 2003 Oct; 98(8):1620-6. PubMed ID: 14534877
[TBL] [Abstract][Full Text] [Related]
51. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
[TBL] [Abstract][Full Text] [Related]
52. Endoscopic management of upper tract urothelial tumors.
Stoller ML; Gentle DL; McDonald MW; Reese JH; Tacker JR; Carroll PR; Best C
Tech Urol; 1997; 3(3):152-7. PubMed ID: 9422447
[TBL] [Abstract][Full Text] [Related]
53. Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma.
Langner C; von Wasielewski R; Ratschek M; Rehak P; Zigeuner R
Urology; 2004 Sep; 64(3):611-6. PubMed ID: 15351619
[TBL] [Abstract][Full Text] [Related]
54. [Tumors of the upper urinary tract: epidemiology, clinical, and diagnosis].
Muñoz Vélez D; Rebassa Llull M; Hidalgo Pardo F; Mus Malleu A; Riera Marí V; Ferrutxe Frau J; Gutiérrez Sanz-Gadea C; Ozonas Moragues M
Arch Esp Urol; 1998 Dec; 51(10):983-9. PubMed ID: 9951120
[TBL] [Abstract][Full Text] [Related]
55. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
[TBL] [Abstract][Full Text] [Related]
56. Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options.
Sijmons RH; Kiemeney LA; Witjes JA; Vasen HF
J Urol; 1998 Aug; 160(2):466-70. PubMed ID: 9679899
[TBL] [Abstract][Full Text] [Related]
57. [Clinical studies on renal pelvic and ureteral carcinoma].
Akino H; Ishida H; Ito Y; Tanase K; Isomatsu Y; Muranaka K; Mori H; Kanamaru H; Okada K
Hinyokika Kiyo; 1997 Apr; 43(4):257-62. PubMed ID: 9161851
[TBL] [Abstract][Full Text] [Related]
58. Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population.
Tan LB; Chang LL; Cheng KI; Huang CH; Kwan AL
BJU Int; 2009 Feb; 103(3):312-6. PubMed ID: 18782312
[TBL] [Abstract][Full Text] [Related]
59. [Clinical prognostic factors in superficial cancer of the urinary bladder].
Busto Catañón L; Sánchez Merino JM; Picallo Sánchez JA; Gelabert Mas A
Arch Esp Urol; 2001 Mar; 54(2):131-8. PubMed ID: 11341116
[TBL] [Abstract][Full Text] [Related]
60. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
